{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:25:02Z","timestamp":1786991102368,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.intimp.2023.110731","type":"journal-article","created":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T07:42:03Z","timestamp":1690962123000},"page":"110731","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["FTY720 attenuates acute colitis via colonic T cells reduction and inhibition of M1 macrophages polarization independent of CCR2-mediated monocytes input"],"prefix":"10.1016","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9364-9084","authenticated-orcid":false,"given":"Jing","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simeng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixiu","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoying","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.intimp.2023.110731_b0005","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.cgh.2019.06.030","article-title":"Progression of Inflammatory Bowel Diseases Throughout Latin America and the Caribbean: A Systematic Review","volume":"18","author":"Kotze","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"7","key":"10.1016\/j.intimp.2023.110731_b0010","doi-asserted-by":"crossref","first-page":"e24729","DOI":"10.1097\/MD.0000000000024729","article-title":"Trends in the epidemiology of inflammatory bowel disease in Colombia by demographics and region using a nationally representative claims database and characterization of inflammatory bowel disease phenotype in a case series of Colombian patients","volume":"100","author":"Juliao-Banos","year":"2021","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.intimp.2023.110731_b0015","doi-asserted-by":"crossref","first-page":"384","DOI":"10.14309\/ajg.0000000000000152","article-title":"ACG Clinical Guideline: Ulcerative Colitis in Adults","volume":"114","author":"Rubin","year":"2019","journal-title":"Am. J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.intimp.2023.110731_b0020","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/ecco-jcc\/jjx008","article-title":"Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders","volume":"11","author":"Magro","year":"2017","journal-title":"J Crohns Colitis"},{"issue":"10080","key":"10.1016\/j.intimp.2023.110731_b0025","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/S0140-6736(16)32126-2","article-title":"Ulcerative colitis","volume":"389","author":"Ungaro","year":"2017","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.intimp.2023.110731_b0030","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.dld.2021.01.012","article-title":"From inflammation to colitis-associated colorectal cancer in inflammatory bowel disease: Pathogenesis and impact of current therapies","volume":"53","author":"Fantini","year":"2021","journal-title":"Dig. Liver Dis."},{"issue":"9","key":"10.1016\/j.intimp.2023.110731_b0035","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s41575-019-0172-4","article-title":"Macrophages in intestinal inflammation and resolution: a potential therapeutic target in IBD","volume":"16","author":"Na","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110731_b0040","doi-asserted-by":"crossref","DOI":"10.3390\/cells9010110","article-title":"Dissecting the Heterogeneity in T-Cell Mediated Inflammation in IBD","volume":"9","author":"Tindemans","year":"2020","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.intimp.2023.110731_b0045","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/s41590-019-0415-0","article-title":"Targeting immune cell circuits and trafficking in inflammatory bowel disease","volume":"20","author":"Neurath","year":"2019","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2023.110731_b0050","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1248\/bpb.31.1177","article-title":"Effects of phosphorylation of immunomodulatory agent FTY720 (fingolimod) on antiproliferative activity against breast and colon cancer cells","volume":"31","author":"Nagaoka","year":"2008","journal-title":"Biol. Pharm. Bull."},{"issue":"7503","key":"10.1016\/j.intimp.2023.110731_b0055","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nature13475","article-title":"Sphingolipid metabolites in inflammatory disease","volume":"510","author":"Maceyka","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2023.110731_b0060","doi-asserted-by":"crossref","first-page":"3496836","DOI":"10.1155\/2019\/3496836","article-title":"FTY720 Effects on Inflammation and Liver Damage in a Rat Model of Renal Ischemia-Reperfusion Injury","volume":"2019","author":"Foster","year":"2019","journal-title":"Mediators Inflamm."},{"issue":"5","key":"10.1016\/j.intimp.2023.110731_b0065","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/bcpt.13720","article-title":"Fingolimod ameliorates acetic acid-induced ulcerative colitis: An insight into its modulatory impact on pro\/anti-inflammatory cytokines and AKT\/mTOR signalling","volume":"130","author":"Makled","year":"2022","journal-title":"Basic Clin. Paharmacol. Toxicol."},{"issue":"4","key":"10.1016\/j.intimp.2023.110731_b0075","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.celrep.2019.03.028","article-title":"YAP Aggravates Inflammatory Bowel Disease by Regulating M1\/M2 Macrophage Polarization and Gut Microbial Homeostasis","volume":"27","author":"Zhou","year":"2019","journal-title":"Cell Rep."},{"issue":"23","key":"10.1016\/j.intimp.2023.110731_b0080","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232314617","article-title":"FTY720 Reduces Lipid Accumulation by Upregulating ABCA1 through Liver X Receptor and Sphingosine Kinase 2 Signaling in Macrophages","volume":"23","author":"Tachibana","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.intimp.2023.110731_b0085","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210562","article-title":"Monocytes transition to macrophages within the inflamed vasculature via monocyte CCR2 and endothelial TNFR2","volume":"219","author":"Mysore","year":"2022","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.intimp.2023.110731_b0090","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/s41385-021-00474-8","article-title":"Disruption of monocyte-macrophage differentiation and trafficking by a heme analog during active inflammation","volume":"15","author":"Schaefer","year":"2022","journal-title":"Mucosal Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2023.110731_b0095","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.jaci.2016.06.033","article-title":"Interleukins (from IL-1 to IL-38), interferons, transforming growth factor beta, and TNF-alpha: Receptors, functions, and roles in diseases","volume":"138","author":"Akdis","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2023.110731_b0100","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1172\/JCI72189","article-title":"VEGF-C-dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease","volume":"124","author":"D'Alessio","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2023.110731_b0105","doi-asserted-by":"crossref","DOI":"10.7573\/dic.212572","article-title":"New developments in ulcerative colitis: latest evidence on management, treatment, and maintenance","volume":"8","author":"Tripathi","year":"2019","journal-title":"Drugs Context"},{"issue":"5","key":"10.1016\/j.intimp.2023.110731_b0110","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/ana.22426","article-title":"Mechanisms of fingolimod's efficacy and adverse effects in multiple sclerosis","volume":"69","author":"Cohen","year":"2011","journal-title":"Ann. Neurol."},{"issue":"suppl_2","key":"10.1016\/j.intimp.2023.110731_b0115","doi-asserted-by":"crossref","first-page":"S678","DOI":"10.1093\/ecco-jcc\/jjx107","article-title":"Targeting S1P in Inflammatory Bowel Disease: New Avenues for Modulating Intestinal Leukocyte Migration","volume":"12","author":"Danese","year":"2018","journal-title":"J. Crohns Colitis"},{"issue":"24","key":"10.1016\/j.intimp.2023.110731_b0120","doi-asserted-by":"crossref","first-page":"14196","DOI":"10.1073\/pnas.95.24.14196","article-title":"Tumor necrosis factor-alpha induces adhesion molecule expression through the sphingosine kinase pathway","volume":"95","author":"Xia","year":"1998","journal-title":"PNAS"},{"issue":"1","key":"10.1016\/j.intimp.2023.110731_b0125","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ccr.2012.11.013","article-title":"Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer","volume":"23","author":"Liang","year":"2013","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.intimp.2023.110731_b0130","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.imlet.2004.09.001","article-title":"The role of sphingosine and ceramide kinases in inflammatory responses","volume":"96","author":"Baumruker","year":"2005","journal-title":"Immunol. Lett."},{"issue":"6","key":"10.1016\/j.intimp.2023.110731_b0135","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1053\/j.gastro.2004.02.070","article-title":"Optimizing anti-TNF treatment in inflammatory bowel disease","volume":"126","author":"Rutgeerts","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.intimp.2023.110731_b0140","doi-asserted-by":"crossref","first-page":"1055256","DOI":"10.3389\/fimmu.2023.1055256","article-title":"Interleukin 17 B regulates colonic myeloid cell infiltration in a mouse model of DSS-induced colitis","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2023.110731_b0145","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/rheumatology\/keq031","article-title":"Transmembrane TNF-alpha: structure, function and interaction with anti-TNF agents","volume":"49","author":"Horiuchi","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.intimp.2023.110731_b0150","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/1756283X13479826","article-title":"Comprehensive review: antitumor necrosis factor agents in inflammatory bowel disease and factors implicated in treatment response","volume":"6","author":"Lichtenstein","year":"2013","journal-title":"Therap. Adv. Gastroenterol."},{"issue":"13","key":"10.1016\/j.intimp.2023.110731_b0155","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1016\/j.molimm.2007.02.026","article-title":"FTY720 ameliorates oxazolone colitis in mice by directly affecting T helper type 2 functions","volume":"44","author":"Daniel","year":"2007","journal-title":"Mol. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2023.110731_b0160","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1002\/eji.200838359","article-title":"FTY720 suppresses the development of colitis in lymphoid-null mice by modulating the trafficking of colitogenic CD4+ T cells in bone marrow","volume":"38","author":"Fujii","year":"2008","journal-title":"Eur. J. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2023.110731_b0165","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1097\/MIB.0000000000000824","article-title":"Role of Monocytes and Intestinal Macrophages in Crohn's Disease and Ulcerative Colitis","volume":"22","author":"Gren","year":"2016","journal-title":"Inflamm. Bowel Dis."},{"issue":"6","key":"10.1016\/j.intimp.2023.110731_b0170","first-page":"2269","article-title":"Unique CD14 intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23\/IFN-gamma axis","volume":"118","author":"Kamada","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2023.110731_b0175","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.3389\/fimmu.2018.01696","article-title":"Peripheral T Cell Depletion by FTY720 Exacerbates Hypoxic-Ischemic Brain Injury in Neonatal Mice","volume":"9","author":"Herz","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110731_b0180","doi-asserted-by":"crossref","first-page":"342","DOI":"10.4049\/jimmunol.175.1.342","article-title":"Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences","volume":"175","author":"Stout","year":"2005","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2023.110731_b0185","first-page":"1297","article-title":"Monocyte and M1 Macrophage-induced Barrier Defect Contributes to Chronic Intestinal Inflammation in IBD","volume":"21","author":"Lissner","year":"2015","journal-title":"Inflamm. Bowel Dis."},{"issue":"6","key":"10.1016\/j.intimp.2023.110731_b0190","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1084\/jem.20180019","article-title":"Tissue-resident macrophages in the intestine are long lived and defined by Tim-4 and CD4 expression","volume":"215","author":"Shaw","year":"2018","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.intimp.2023.110731_b0195","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/mi.2012.89","article-title":"Resident and pro-inflammatory macrophages in the colon represent alternative context-dependent fates of the same Ly6Chi monocyte precursors","volume":"6","author":"Bain","year":"2013","journal-title":"Mucosal Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2023.110731_b0200","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1161\/ATVBAHA.112.300329","article-title":"Peptide inhibitor of CXCL4-CCL5 heterodimer formation, MKEY, inhibits experimental aortic aneurysm initiation and progression","volume":"33","author":"Iida","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"26","key":"10.1016\/j.intimp.2023.110731_b0205","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1038\/onc.2017.2","article-title":"The protumorigenic potential of FTY720 by promoting extramedullary hematopoiesis and MDSC accumulation","volume":"36","author":"Li","year":"2017","journal-title":"Oncogene"},{"issue":"33","key":"10.1016\/j.intimp.2023.110731_b0210","doi-asserted-by":"crossref","first-page":"6016","DOI":"10.3748\/wjg.v23.i33.6016","article-title":"Dextran sodium sulfate colitis murine model: An indispensable tool for advancing our understanding of inflammatory bowel diseases pathogenesis","volume":"23","author":"Eichele","year":"2017","journal-title":"World J. Gastroenterol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923010561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923010561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T09:33:02Z","timestamp":1736415182000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923010561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":41,"alternative-id":["S1567576923010561"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110731","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FTY720 attenuates acute colitis via colonic T cells reduction and inhibition of M1 macrophages polarization independent of CCR2-mediated monocytes input","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110731","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110731"}}